Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproic Acid for Autosomal Dominant Retinitis Pigmentosa
NCT01233609Phase 2Completed
- Sponsor
- Foundation Fighting Blindness
- Start
- Nov 2010
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of valproic acid in retinitis pigmentosa (RP), sponsored by Foundation Fighting Blindness. Started Nov 2010; status: completed.
02
Drugs
valproic acid
03
Conditions
retinitis pigmentosa (RP)
Beyond the preview
Go deeper on NCT01233609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01233609.